首页 | 本学科首页   官方微博 | 高级检索  
     

更昔洛韦联合薄芝糖肽治疗婴儿巨细胞病毒性肝炎疗效观察
引用本文:崔丽霞. 更昔洛韦联合薄芝糖肽治疗婴儿巨细胞病毒性肝炎疗效观察[J]. 中国医药科学, 2011, 0(10): 98+100
作者姓名:崔丽霞
作者单位:郑州市妇幼保健院
摘    要:目的 研究更昔洛韦联合薄芝糖肽治疗婴儿巨细胞病毒性肝炎的疗效.方法 选择2008~2010年住院的60例巨细胞病毒性肝炎患儿,随机分为治疗组和对照组.治疗组给予更昔洛韦联合薄芝糖肽;对照组单用更昔洛韦,两组其他辅助治疗相同.结果 治疗组血清总胆红素、直接胆红素及ALT较对照组明显下降,差异有统计学意义(P<0.05)....

关 键 词:更昔洛韦  薄芝糖肽  巨细胞病毒性肝炎  婴儿

Therapeutic Effect Observation of Ganciclovir United with Bozhi Glycopeptide for Infant Cytomegalovirus Hepatitis
CUI Lixia. Therapeutic Effect Observation of Ganciclovir United with Bozhi Glycopeptide for Infant Cytomegalovirus Hepatitis[J]. China Medicine and Pharmacy, 2011, 0(10): 98+100
Authors:CUI Lixia
Affiliation:CUI Lixia Department of Pediatrics,Zhengzhou Maternal and Child Health Hospital,Zhengzhou 450012,China
Abstract:Objective To investigate the therapeutic effect for infant cytomegalovirus hepatitis by ganciclovir united with bozhi Glycopeptide.Methods Infant cytomegalovirus hepatitis caused by HCMV(n =60),were divided into two groups.Treated group received ganciclovir and bozhi Glycopeptide,and control group received only ganciclovir.Results The serum TB,DB and ALT were obviously decrease in treatment group than control grou(pP <0.05).Conclusion Treating infant cytomegalovirus hepatitis with ganciclovir and bozhi Glycopeptide were evident effect.
Keywords:Ganciclovir  Bozhi glycopeptide  Cytomegalovirus hepatitis  Infant
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号